Consistent with this, we found GSDMD inhibition could improve the inflammatory environment of the brain and reduced inflammation-associated neuronal toxicity or death, thereby shrinking brain infarcts and improving the prognosis of stroke. This evidence concerns the gene GSDMD and stroke disorder.